| 1 |
Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: an emerging player in iron homeostasis and inflammation[J]. Annu Rev Nutr, 2017, 37:103-130.
|
| 2 |
Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition[J]. Mol Cell, 2002, 10(5):1033-1043.
|
| 3 |
Goetz DH, Willie ST, Armen RS, et al. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin[J]. Biochemistry, 2000, 39(8):1935-1941.
|
| 4 |
Kjeldsen L, Johnsen AH, Sengeløv H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993, 268(14):10425-10432.
|
| 5 |
Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview[J]. Biochim Biophys Acta, 2000, 1482(1-2): 9-24.
|
| 6 |
Meyers K, López M, Ho J, et al. Lipocalin-2 deficiency may predispose to the progression of spontaneous age-related adiposity in mice[J]. Sci Rep, 2020, 10(1):14589.
|
| 7 |
Shashidharamurthy R, Machiah D, Aitken JD, et al. Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice[J]. Arthritis Rheum, 2013, 65(4):1064-1073.
|
| 8 |
Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans[J]. Genomics, 1997, 45(1):17-23.
|
| 9 |
Seth P, Porter D, Lahti-Domenici J, et al. Cellular and molecular targets of estrogen in normal human breast tissue[J]. Cancer Res, 2002, 62(16): 4540-4544.
|
| 10 |
Moreno-Navarrete JM, Manco M, Ibáñez J, et al. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance[J]. Int J Obes (Lond), 2010, 34(2):240-249.
|
| 11 |
Cowland JB, Sørensen OE, Sehested M, et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha[J]. J Immunol, 2003, 171(12):6630-6639.
|
| 12 |
Furutani M, Arii S, Mizumoto M, et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method[J]. Cancer Lett, 1998, 122(1-2):209-214.
|
| 13 |
Zhang PX, Zhang FR, Xie JJ, et al. Expression of NGAL and NGALR in human embryonic, fetal and normal adult tissues[J]. Mol Med Rep, 2012, 6(4):716-722.
|
| 14 |
Huang HL, Chu ST, Chen YH. Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period[J]. J Endocrinol, 1999, 162(1):11-19.
|
| 15 |
Borkham-Kamphorst E, Drews F, Weiskirchen R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation[J]. Liver Int, 2011, 31(5):656-665.
|
| 16 |
Aigner F, Maier HT, Schwelberger HG, et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart[J]. Am J Transplant, 2007, 7(4):779-788.
|
| 17 |
Zhang CF, Wang HJ, Tong ZH, et al. The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients[J]. Eur Rev Med Pharmacol Sci, 2020, 24(10):5604-5617.
|
| 18 |
Imoto Y, Wakasaki A, Izumida K, et al. Analysis of the diagnostic capabilities of urinary neutrophil gelatinase-associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care intensive care unit admission[J]. J Clin Lab Anal, 2021, 35(7): e23852.
|
| 19 |
Xu Z, Jiang M, Bai X, et al. Identification and verification of potential core genes in pediatric septic shock[J]. Comb Chem High Throughput Screen, 2022, 25(13):2228-2239.
|
| 20 |
Wang T, Han JG, Dong W, et al. LCN2 and ELANE overexpression induces sepsis[J]. Medicine (Baltimore), 2024, 103(7):e37255.
|
| 21 |
Moro H, Bamba Y, Nagano K, et al. Dynamics of iron metabolism in patients with bloodstream infections: a time-course clinical study[J]. Sci Rep, 2023, 13(1): 19143.
|
| 22 |
Chen P, Chen J, Ye J, et al. Identification of an immune-related gene diagnostic model and potential drugs in sepsis using bioinformatics and pharmacogenomics approaches[J]. Infect Drug Resist, 2023, 16:5665-5680.
|
| 23 |
Fassett RG, Venuthurupalli SK, Gobe GC, et al. Biomarkers in chronic kidney disease: a review[J]. Kidney Int, 2011, 80(8):806-821.
|
| 24 |
Lacquaniti A, Ceresa F, Campo S, et al. Acute kidney injury and sepsis after cardiac surgery: the roles of tissue inhibitor metalloproteinase-2, insulin-like growth factor binding protein-7, and mid-regional pro-adrenomedullin[J]. J Clin Med, 2023, 12(16):5193.
|
| 25 |
Zarbock A, Nadim MK, Pickkers P, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup[J]. Nat Rev Nephrol, 2023, 19(6):401-417.
|
| 26 |
Deng Z, He M, Hu H, et al. Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation[J]. Autophagy, 2024, 20(1):151-165.
|
| 27 |
Zhang W, Zhou P, Jiang X, et al. Negative regulation of Tec kinase alleviates LPS-induced acute kidney injury in mice via the TLR4/NF-κB signaling pathway[J]. Biomed Res Int, 2020, 2020:3152043.
|
| 28 |
He Z, Wang H, Yue L. Endothelial progenitor cells-secreted extracellular vesicles containing microRNA-93-5p confer protection against sepsis-induced acute kidney injury via the KDM6B/H3K27me3/TNF-α axis[J]. Exp Cell Res, 2020, 395(2):112173.
|
| 29 |
Urbschat A, Thiemens AK, Mertens C, et al. Macrophage-secreted Lipocalin-2 Promotes regeneration of injured primary murine renal tubular epithelial cells[J]. Int J Mol Sci, 2020, 21(6):2038.
|
| 30 |
Lu F, Inoue K, Kato J, et al. Functions and regulation of lipocalin-2 in gut-origin sepsis: a narrative review[J]. Crit Care, 2019, 23(1):269.
|
| 31 |
Du H, Liang L, Li J, et al. Lipocalin-2 alleviates LPS-induced inflammation through alteration of macrophage properties[J]. J Inflamm Res, 2021, 14:4189-4203.
|
| 32 |
Zhang ZX, Peng J, Ding WW. Lipocalin-2 and intestinal diseases[J]. World J Gastroenterol, 2024, 30(46):4864-4879.
|
| 33 |
Helbing DL, Böhm L, Witte OW. Sepsis-associated encephalopathy[J]. CMAJ, 2018, 190(36):E1083.
|
| 34 |
Chaudhry N, Duggal AK. Sepsis associated encephalopathy[J]. Adv Med, 2014, 2014:762320.
|
| 35 |
Guo C, Li W, Liu Y, et al. LCN2 induces neuronal loss and facilitates sepsis-associated cognitive impairments[J]. Cell Death Dis, 2025, 16(1):146.
|
| 36 |
Hu J, Chen Z, Wang J, et al. Identification and evaluation of Lipocalin-2 in sepsis-associated encephalopathy via machine learning approaches[J]. J Inflamm Res, 2025, 18:3843-3858.
|
| 37 |
Olson B, Zhu X, Norgard MA, et al. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment[J]. Brain Behav Immun, 2021, 97:102-118.
|
| 38 |
Gong H, Xia Y, Jing G, et al. Berberine alleviates neuroinflammation by downregulating NFκB/LCN2 pathway in sepsis-associated encephalopathy:network pharmacology, bioinformatics, and experimental validation[J]. Int Immunopharmacol, 2024, 133:112036.
|
| 39 |
Xu X, Yang T, An J, et al. Liver injury in sepsis:manifestations, mechanisms and emerging therapeutic strategies[J]. Front Immunol, 2025, 16:1575554.
|
| 40 |
Jiang Y, Jiang ZT, Zhao G, et al. LCN2 depletion aggravates sepsis-induced liver injury by regulating PTGS2-dependent ferroptosis [J]. Int J Med Sci, 2024, 21(14): 2770-2780.
|
| 41 |
Li Y, Li L, Zhang Y, et al. Lipocalin-2 silencing alleviates sepsis-induced liver injury through inhibition of ferroptosis[J]. Ann Hepatol, 2025, 30(1):101756.
|
| 42 |
Singam A. Myocardial injury as a harbinger of multi-organ failure in septic shock: a comprehensive review[J]. Cureus, 2024, 16(2):e55021.
|
| 43 |
Liu W, Guo X, Jin L, et al. Lipocalin-2 participates in sepsis-induced myocardial injury by mediating lipid accumulation and mitochondrial dysfunction[J]. Front Cardiovasc Med, 2022, 9:1009726.
|
| 44 |
Huang Y, Zhang N, Xie C, et al. Lipocalin-2 in neutrophils induces ferroptosis in septic cardiac dysfunction via increasing labile iron pool of cardiomyocytes[J]. Front Cardiovasc Med, 2022, 9:922534.
|
| 45 |
Pei H, Qu J, Chen J, et al. S100A9 as a key myocardial injury factor interacting with ATP5 exacerbates mitochondrial dysfunction and oxidative stress in sepsis-induced cardiomyopathy[J]. J Inflamm Res, 2024, 17:4483-4503.
|
| 46 |
Huang Y, Li L, Li Y, et al. Knockdown of LncRNA Lcn2-204 alleviates sepsis-induced myocardial injury by regulation of iron overload and ferroptosis[J]. J Mol Cell Cardiol, 2024, 192:79-93.
|
| 47 |
Gong T, Fu Y, Wang Q, et al. Decoding the multiple functions of ZBP1 in the mechanism of sepsis-induced acute lung injury[J]. Commun Biol, 2024, 7(1):1361.
|
| 48 |
Ye R, Wei Y, Li J, et al. Plasma-derived extracellular vesicles prime alveolar macrophages for autophagy and ferroptosis in sepsis-induced acute lung injury[J]. Mol Med, 2025, 31(1):40.
|
| 49 |
Saiga H, Nishimura J, Kuwata H, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium[J]. J Immunol, 2008, 181(12):8521-8527.
|
| 50 |
An HS, Yoo JW, Jeong JH, et al. Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation[J]. Int J Biol Sci, 2023, 19(4):1163-1177.
|
| 51 |
Zhan J, Chen J, Deng L, et al. Exploring the ferroptosis-related gene lipocalin 2 as a potential biomarker for sepsis-induced acute respiratory distress syndrome based on machine learning[J]. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(4):167101.
|
| 52 |
Qian G, Fang H, Chen A, et al. A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection[J]. Front Immunol, 2023, 14: 1257834.
|
| 53 |
Srinivasan G, Aitken JD, Zhang B, et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis[J]. J Immunol, 2012, 189(4):1911-1919.
|
| 54 |
Cao S, Schnelzer A, Hannemann N, et al. The transcription factor FRA-1/AP-1 controls Lipocalin-2 expression and inflammation in sepsis model[J]. Front Immunol, 2021, 12:701675.
|
| 55 |
Chen Y, Guo X, Zeng Y, et al. Oxidative stress induces mitochondrial iron overload and ferroptotic cell death[J]. Sci Rep, 2023, 13(1):15515.
|
| 56 |
Jiang C, Hou M, Sun S, et al. Targeting Lcn2 to inhibit myocardial cell ferroptosis is a potential therapy for alleviating septic cardiomyopathy [J]. Inflammation, 2025, 48(5):3066-3076.
|
| 57 |
Wang H, Wang Z, Gao Y, et al. STZ-induced diabetes exacerbates neurons ferroptosis after ischemic stroke by upregulating LCN2 in neutrophils[J]. Exp Neurol, 2024, 377: 114797.
|
| 58 |
Fei X, Dou Y, Yang Y, et al. Lipocalin-2 inhibition alleviates neural injury by microglia ferroptosis suppression after experimental intracerebral hemorrhage in mice via enhancing ferritin light chain expression[J]. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(7): 167435.
|
| 59 |
Nikaido Y, Midorikawa Y, Furukawa T, et al. The role of neutrophil gelatinase-associated lipocalin and iron homeostasis in object recognition impairment in aged sepsis-survivor rats[J]. Sci Rep, 2022, 12(1): 249.
|
| 60 |
Zaitoun T, Megahed M, Elghoneimy H, et al. Renal arterial resistive index versus novel biomarkers for the early prediction of sepsis-associated acute kidney injury[J]. Intern Emerg Med, 2024, 19(4):971-981.
|
| 61 |
Yao RQ, Shen Z, Ma QM, et al. Combination of transcriptional biomarkers and clinical parameters for early prediction of sepsis indued acute respiratory distress syndrome[J]. Front Immunol, 2022, 13: 1084568.
|
| 62 |
Bergquist M, Samuelsson L, Larsson A, et al. TNFR1, TNFR2, neutrophil gelatinase-associated lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort [J]. Sci Rep, 2020, 10(1):15350.
|
| 63 |
Gong F, Li R, Zheng X, et al. OLFM4 regulates lung epithelial cell function in sepsis-associated ARDS/ALI via LDHA-Mediated NF-κB signaling[J]. J Inflamm Res, 2021, 14:7035-7051.
|
| 64 |
De La Fuente A, López-Sánchez J, Vaquero-Roncero LM, et al. Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuum[J]. Int J Infect Dis, 2024, 146:107142.
|